6th Cytokine-Based Drug Development Summit will bring together leaders in the fields to discuss expanding the application of cytokine-based drugs for the potential treatment of Oncology, Immunology, and Inflammation disease indications.
The 6th Cytokine-Based Drug Development Summit unites top leaders from Candel, Regeneron, Sanofi, and more to drive the next era of cytokine-based immunotherapies. Discussions will tackle toxicity reduction, enhanced specificity, and multi-cytokine approaches, while exploring pro-drug, pulsed, and targeted immunomodulation. Join experts redefining success in oncology, immunology, and inflammation by bridging preclinical breakthroughs with real-world.
Find out more
